Ro Stock
Ro is the healthcare technology company building a patient-centric healthcare system. Ro's vertically integrated primary care platform powers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care.
Sign up today for more details and to buy or sell Ro Stock
Buy + SellRo Funding
Gain insight into Ro funding rounds, the table below shows Ro capital raises and the dates of Ro financing history.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Aug 03, 2017 | Seed | $2.87M | ||
Sep 18, 2018 | Series A | $3.09M | ||
Sep 18, 2018 | Series A | $39.99M | ||
Sep 18, 2018 | Series A | $19.95M | ||
Apr 15, 2019 | Series B | $85.54M | ||
Jul 23, 2020 | Series C | $39.04M | ||
Jul 23, 2020 | Series C | $50.25M | ||
Jul 23, 2020 | Series C | $33.72M | ||
Mar 05, 2021 | Series D | $500.00M | ||
Feb 15, 2022 | Series D | $100.00M |
See Valuations and Financials
Gain insights Into Ro Stock Valuation + Share Prices
Get started to view real-time data on Ro stock including most recent valuation and historical share price information.
Get StartedRo Management Team
Director
Tony West
SVP, Product
Jessica Prager
Chief Technology Officer
Todd Levy
Co-Founder, CEO, Director
Zachariah Reitano
Co-Founder, Chief Product Officer, Director
Saman Rahmanian
Director
Rick Heitzmann
CFO
Aaron Susman
Director
Hemant Taneja
Chief Medical Officer
Melynda Barnes
Co-Founder, Director
Rob Schutz
Director
Alexis Ohanian
Ro Major Investors
Altimeter Capital Management LLC
BoxGroup
Dragoneer Investment Group
FirstMark Capital LLC
General Catalyst Partners LLC
Initialized Capital
Seven Seven Six
ShawSpring Partners
SignalFire
Sinai Ventures
Slow Ventures
The Baupost Group
The Chernin Group
The Radcliff Companies
Torch Venture Capital
TQ Ventures
Tusk Ventures